Lymphoma

Lymphoma

Bispecifics, BTK inhibitors, and immunotherapy advances in lymphoma treatment, featuring experts Dr. Rahul Gosain, Dr. Julie Vose, and Dr. Rohit Gosain at OncUpdates conference.

Lymphoma

02/26/2026

Bispecifics, BTK Inhibitors, and Immunotherapy Drive Lymphoma Advances

Julie Vose, MD, MBARahul Gosain, MD, MBARohit Gosain, MD

Lymphoma

01/15/2026

Insights on CAR-NK Therapy and Hodgkin Lymphoma Updates at ASH 2025

Sam Yamshon, MDAndrew Evens, DO, MBA, MSc

1. Expert oncologists Kingsley Nnawuba and Urshila Durani discuss advancements in lymphoma treatment, including ESMO guidelines, immunotherapy, and combination therapies for improved patient outcomes.

Lymphoma

01/13/2026

Oncologists Review Practice-Changing Lymphoma Findings From ASH 2025

Kingsley Nnawuba, MDUrshila Durani, MD, MPH

1. Experienced medical professionals discussing Sonrotoclax in mantle cell lymphoma at ASH 2025 clinical conference.

Lymphoma

12/20/2025

Experts Discuss Sonrotoclax and Lymphoma Trials at ASH 2025

Agrima Mian, MDSam Yamshon, MD

Imaging for oncological research on follicular lymphoma, featuring MDs Urshila Durani and Joshua Brody, highlighting practice-changing data from EPCORE FL-1 clinical trial in a skyline cityscape background.

Lymphoma

12/17/2025

Primary Results From EPCORE FL-1 Presented at ASH 2025

Urshila Durani, MD, MPHJoshua Brody, MD